Article thumbnail

Natural products as starting points for future anti-malarial therapies: going back to our roots?

By Timothy NC Wells
Topics: Reviews
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2009). A clinical trial of Veronia amygdalina in the treatment of uncomplicated malaria.
  2. (1988). Activity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitro. Antimicrob Agents Chemother
  3. (2006). Agency: Guideline on non-clincal documentation for herbal medicinal products in application for marketing authorisation.
  4. (2009). ANDI Task Force: The African Network for Drugs and Diagnostics Innovation. Lancet
  5. (1996). Angenot L: Antimalarial activity of crytolepine and some other anhydronium bases. Phytother Res
  6. (2009). Angulo-Barturen I: Improved murine model of malaria using Plasmodium falciparum competent strains and non-myodepleted NOD-scid IL2-Rgamma null mice engrafted with human erythrocysts. Antimicrob Agents Chemother
  7. (2010). Antimalarial activity and toxicity evaluation of a quantified Nauclea pobeguinii extract.
  8. (1997). Antimalarial activity of tropical meliaceae extracts and gedunin derivatives.
  9. (2009). Antimalarial compounds isolated from plants used in traditional medicine.
  10. (2007). Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg
  11. (2003). Arnason JT: Antimalarial activities of gedunin and 7-methoxygedunin and synergistic activities with dillaiol. Ann Appl Biol
  12. (1993). Atovaquone - a novel broad-spectrum anti-infective drug. Parasitol Today
  13. (2008). Bangsberg DR: The Analgesic and Antiplasmodial Activities and Toxicology of Vernonia amygdalina.
  14. (2008). Bembenek SD: Ligand Binding Efficiency: Trends Physical Basis and Implications.
  15. (2004). Charman WN: Identification of an antimalarial synthetic trioxolane drug development candidate. Nature
  16. (2009). Clinical trial of Pr259ct1 versus artesunate-amodiaquine (ASAQ) in patients with uncomplicated malaria in the Democratic Republic of Congo (DRC).
  17. (2010). Diagana TT: Spiroindolones, a new and potent chemotype for 1 the treatment of malaria. Science
  18. (1992). Druilhe P: Pharmacokinetics of quinine, quinidine and cinchonine when given as combination. Southeast Asian J Trop Med Public Health
  19. (1994). Efficacy of Ro 42-1611 (arteflene) in the treatment of patients with mild malaria: a clinical trial in Cameroon. Trop Med Parasitol
  20. (2010). Elisabetsky E: Ethnopharmacology, sustainable development and cooperation: the importance of gathering clinical data during field surveys.
  21. (1950). Fawaz G: Naphthoquinone Antimalarials. XXIV. A New Synthesis of Lapinone.
  22. (1999). From Changshan to a new antimalarial drug.
  23. (2010). GA: New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays.
  24. (2010). Garcia-Bustos JF: Thousands of chemical starting points for antimalarial lead identification. Nature 2010, 465:305-10. Wells Malaria Journal 2011, 10(Suppl 1):S3 Page 10 of 125. Guiguemde
  25. (2000). guidelines for methodologies on research and evaluation of traditional medicine.
  26. Guidelines for the treatment of malaria World Health Organisation.
  27. (2005). Herb and supplement use in the US adult population. Clin Ther
  28. (1997). Herbal remedies for malaria. Trop Doct
  29. (2010). Heyerik A potential synergism with artemsinin against malaria and cancer. Molecules
  30. (2010). Idle JR: Xenobiotic metabolism: a view through the metabolometer. Chem Res Toxicol
  31. (2010). Is the tide turning for new malaria medicines? Science
  32. (1988). Krettli AU: In vitro activity of natural and synthetic naphthoquinones against erythrocytic stages of Plasmodium falciparum.
  33. (2000). Lal S: Comparative efficacy of Ayush-64 vs chloroquine in vivax malaria. Current Science
  34. (2008). Late onset of bladder urothelial carcinoma after kidney transplantation for endstage aristolochic acid nephropathy: a case series with 15-year follow-up.
  35. (2001). Molecular Complexity and its impact on the probability of finding leads for drug discovery.
  36. (2008). MS: Herbal Artemisiae annuae tea preparation compared to sulfadoxinepyrimethaminein the treatment of uncomplicated falciparum malaria in adults: a randomized double-blind clinical trial. Trop Doct
  37. (2008). MV: Analysis of the adult human plasma metabolome. Pharmacogenomics
  38. (2004). Neem (Azadirachta indica)
  39. Novartis natural products paper in this journal.
  40. (2009). NP: Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.
  41. (2007). Obioma MS: Fractionated neem leaf extract is safe and increases CD4+ cell levels in HIV/AIDS patients.
  42. (2004). Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). Am J Trop Med Hyg
  43. (2007). Prolonged engraftment of human hepatocytes in mice transgenic for the deleted form of human hepatocyte growth factor. Hepatol Res
  44. (1993). Quinine’s Predecessor: Francesco Torti and the Early History of Cinchona,. Saul Johns Hopkins
  45. (2004). Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. Trans R Soc Trop Med Hyg
  46. (1993). Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet
  47. (1987). RJM: Potentiation of the antimalarial activity of Qinghaosu by methoxylated flavones. Trans R Soc Trop Med Hyg
  48. (2004). S: Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov
  49. (2009). Saludes JP: Drug development from marine natural products. Nature Reviews Drug Discovery
  50. (2010). Siallo D: Argemone mexicana decoction versus artesunate-amodiaquine for the management of malaria in Mali: policy and public-health implication. Trans R Soc Trop Med Hyg
  51. (2009). Synthesis and biological evaluation of febrifugine analogues as potential antimalarial agents. Bioorg Med Chem
  52. (2010). Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol
  53. (1946). TC: Ch’ang Shan, a Chinese Antimalarial Herb Science. Science
  54. (2001). The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosinecytosine sites. Nat Struct Biol
  55. (2006). TR: Gene expression signature based chemical genomic prediction identifies a novel class of Hsp90 pathway modifiers. Cancer Cell
  56. (2004). Traditional herbal medicines for malaria. British Medical Journal
  57. (2008). Verlinde CL: Genomic-scale prioritization of drug targets: the TDR Targets database. Nat Rev Drug Discov
  58. (2010). Vlietinck A: Assessment of the Short-Term Safety and Tolerability of a
  59. (2009). White NJ: Artemisinin resistance in Plasmodium falciparum malaria.
  60. (2008). Winzeler EA: In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.